Attorney General

Schedule I - Controlled Substances

Effective Date: 03/07/2019 to 05/13/2019

Rule Type: Expired Emergency Rules & Regulations

Reference Number: 015.0015.1.03072019

Chapter 1

Additional Controlled Substances

EMERGENCY RULES ARE NO LONGER IN EFFECT 120 DAYS AFTER FILING WITH THE SECRETARY OF STATE.

Section 1. Purpose. The purpose of these rules is to add, delete, and reschedule controlled substances in the Wyoming Controlled Substances Act of 1971. Some changes will be made to similarly control a substance in response to the publication of a final order in the Federal Register designating that substance as a controlled substance under federal law. Other changes will be made at the discretion of the Wyoming Attorney General, in his capacity as the Commissioner of Drugs and Substances Control, with the advice of the Advisory Board on Drugs and Substances Control.

Section 2. Authority. The Commissioner of Drugs and Substances Control's rulemaking authority is found at Wyoming Statute § 35-7-1011(a) and (d), which allow the Commissioner to add, delete, and reschedule substances to the control schedules pursuant to the procedures of the Wyoming Administrative Procedure Act.

Section 3. Additional Controlled Substances. The Commissioner of Drugs and Substances Control adds the following substances to Schedule I:

(a) Synthetic cannabinoids:

(i) (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, commonly known as 5F-AMB;

(ii) [N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide, commonly known as ADB-FUBINACA;

(iii) [Methyl 2-({1-[(4-fluorophenyl)methyl]-1 Hindazole-3-carbonyl}amino)-3-methylbutanoate], commonly known as FUB-AMB

(iv) Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, commonly known as NM2201; CBL2201, and its isomers, ethers, salts, and salts of isomers, esters, and ethers;

(v) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, commonly known as 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78, and its isomers, ethers, salts, and salts of isomers, esters, and ethers;

(vi) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate, commonly known as MMB-CHMICA, AMB-CHMICA, and its isomers, ethers, salts, and salts of isomers, esters, and ethers;

(vii) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide, commonly known as 5F-CUMYL-P7AICA, and its isomers, ethers, salts, and salts of isomers, esters, and ethers;

(viii) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide commonly known as MAB-CHMINACA or ADB-CHMINACA;

(ix) methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate commonly known as 5F-ADB or 5F-MDMB-PINACA;

(x) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate commonly known as MDMB-CHMICA or MMB-CHMINACA; and

(xi) methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate commonly known as MDMB-FUBINACA.

(b) Synthetic opioid analgesics:

(i) trans-3,4-dichloro-N-[2-dimethylamino)cyclohexyl]-N-methyl-benzamide, commonly known as acetyl fentanyl;

(ii) para-fluorobutyryl fentanyl, commonly known as p-FBF;

(iii) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, commonly known as acetyl fentanyl; and

(iv) 3,4-dichloro-N-[(1dimethylamino)cyclohexylmethyl]benzamide), commonly known as AH-7921

(c) Analgesics:

(i) 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide, commonly known as W-18.

(d) Synthetic opioids:

(i) N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (commonly known as butyryl fentanyl);

(ii) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N- phenylpropanamide, (commonly known as beta-hydroxythiofentanyl) and its isomers, ethers, salts, and salts of isomers, esters, and ethers;

(iii) N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide, (commonly known as furanyl fentanyl) and its isomers, ethers, salts, and salts of isomers, esters, and ethers;

(iv) para-fluoroisobutyryl fentanyl [N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide] (commonly known as 4-fluoroisobutyryl fentanyl) and its isomers, ethers, salts, and salts of isomers, esters, and ethers;

(v) acryloylfentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide], (commonly known as acryl fentanyl) and its isomers, ethers, salts, and salts of isomers, esters, and ethers;

(vi) [N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide], (commonly known as tetrahydrofuranyl fentanyl) and its isomers, ethers, salts, and salts of isomers, esters, and ethers;

(vii) [N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide], (commonly known as ocfentanil) and its isomers, ethers, salts, and salts of isomers, esters, and ethers; and

(viii) Fentanyl related substances that are not currently listed in any schedule of the Wyoming Controlled Substances Act and their isomers, ethers, salts, and salts of isomers, esters, and ethers.

(e) Synthetic cathinone:

(i) N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone, commonly known as N-ethylpentylone, ephylone.